Dashi Deng
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
Papers in
- Surgery 9
- Bladder and Urothelial Cancer Treatments 9
- Urinary and Genital Oncology Studies 2
-
- Nanoplatforms for cancer theranostics 8
- Co-authors
- Zhuang Liu (9 shared papers)Guangzhi Li (16 shared papers)Song Wu (14 shared papers)Qifang Lei (7 shared papers)Wanwan Shen (2 shared papers)Yiyun Cheng (2 shared papers)Ziliang Dong (2 shared papers)Zhisheng Xiao (3 shared papers)
In The Last Decade
Dashi Deng
20 papers receiving 697 citations
Peers
Comparison fields: 5 of 70
- Biomaterials 153
- Biomedical Engineering 409
- Microbiology 43
- Pharmaceutical Science 30
- Biotechnology 41
Countries citing papers authored by Dashi Deng
This map shows the geographic impact of Dashi Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dashi Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dashi Deng more than expected).
Fields of papers citing papers by Dashi Deng
This network shows the impact of papers produced by Dashi Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dashi Deng. The network helps show where Dashi Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Dashi Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 206 | |
| 2 | 2019 | 129 | |
| 3 | 2020 | 88 | |
| 4 | 2019 | 87 | |
| 5 | 2020 | 29 | |
| 6 | 2022 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 20 | |
| 9 | 2024 | 16 | |
| 10 | 2024 | 16 | |
| 11 | 2024 | 13 | |
| 12 | 2024 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2024 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Dashi Deng
Dashi Deng is a scholar working on Surgery, Biomedical Engineering, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 702 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Nanoplatforms for cancer theranostics (8 papers), Immune cells in cancer (3 papers), Ferroptosis and cancer prognosis (2 papers), Photodynamic Therapy Research Studies (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Urinary and Genital Oncology Studies (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Biomaterials (153 citations), Biomedical Engineering (409 citations), Microbiology (43 citations), Pharmaceutical Science (30 citations) and Biotechnology (41 citations). Dashi Deng has collaborated with scholars based in China, Germany and Japan. Frequent co-authors include Zhuang Liu, Guangzhi Li, Song Wu, Qifang Lei, Wanwan Shen, Yiyun Cheng, Ziliang Dong, Zhisheng Xiao, Guixiao Huang and Enpu Zhang. Their work appears in journals such as Advanced Science, Advanced Functional Materials, Biomaterials, Advanced Therapeutics and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.